首页> 中文期刊> 《中国中医药信息杂志》 >河北医科大学第二医院注射用丹参多酚酸盐临床应用评价

河北医科大学第二医院注射用丹参多酚酸盐临床应用评价

         

摘要

Objective To investigate the use of salvianolate injection for inpatients in our hospital; To primarily evaluate its rationality and security in clinic.Methods Medical records using the salvianolate injection from December 2013 to March 2014 were surveyed statistically and analyzed in respect of patient gender and age, department, disease diagnosis, usage and dosage, solvent types, treatment course, medicine combination, occurence of ADR, etc.Results Totally 600 cases of inpatients receiving salvianolate injection were collected, about 69.33% consistent with the indication, 67.00% with a correct single dosage, and 52.50% with a correct treatment course. In the clinical application of salvianolate injection, a high rate of unreasonable usage was found in indication, single dosage, treatment course and medicine combination.ConclusionBecause the problems still existed in the use of salvianolate injection, it should be used strictly according to the medicine instructions and General Principles for Clinical Application of Traditional Chinese Medicine Injection to ensure clinical medication safety.%目的:了解河北医科大学第二医院(以下简称“我院”)住院患者注射用丹参多酚酸盐使用情况,对其临床应用合理性进行初步评价。方法采用Excel表,收集我院2013年12月-2014年3月使用注射用丹参多酚酸盐的住院病历600份,对患者性别与年龄、涉及科室、疾病诊断、用法用量、所用溶媒、疗程、合并用药、不良反应等因素进行分析。结果600例患者中,注射用丹参多酚酸盐的适应证相符率为69.33%,单次用药剂量合格率为67.00%,疗程合格率为52.50%。注射用丹参多酚酸盐在适应证、单次用药剂量、用药疗程及联合用药等方面均存在不规范现象。结论我院注射用丹参多酚酸盐存在不合理用药现象,建议严格按照药品说明书和《中药注射剂临床使用基本原则》规定使用,以保证临床用药安全。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号